CNMD
CONMED Corporation
45.40$
+0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 44.8% | 44.3% | 44.9% | 44.7% | 43.5% | 42.7% | 47.4% | 47.4% | 53.3% | 42.9% | 42.1% | 42.5% | 45.2% | |
| 55.2% | 55.7% | 55.1% | 55.3% | 56.5% | 57.3% | 52.6% | 52.6% | 46.7% | 57.1% | 57.9% | 57.5% | 54.8% | |
| 4.1% | 4.3% | 4.4% | 4.2% | 4.3% | 3.8% | 4.1% | 4.1% | 4.1% | 4.0% | 5.2% | 4.5% | 4.4% | |
| 41.1% | 36.1% | 39.5% | 36.9% | 31.5% | 38.3% | 46.6% | 35.2% | 36.1% | 44.7% | 44.7% | 42.4% | 42.0% | |
| 45.2% | 40.4% | 43.9% | 41.1% | 35.8% | 42.2% | 49.0% | 40.5% | 40.9% | 39.2% | 49.8% | 46.9% | 44.0% | |
| 9.9% | 15.3% | 11.2% | 14.2% | 20.7% | 15.2% | 3.6% | 12.2% | 5.7% | 17.9% | 8.0% | 10.6% | 10.8% | |
| 3.3% | 2.9% | 3.1% | 2.9% | 2.9% | 2.6% | 2.6% | 2.3% | 2.2% | 2.0% | 2.2% | 2.3% | 2.2% | |
| 6.7% | 12.4% | 8.1% | 11.3% | 17.8% | 12.6% | 2.4% | 8.7% | 1.3% | 7.8% | 5.8% | 9.1% | 6.1% | |
| 1.5% | 2.3% | 1.8% | 2.3% | 2.4% | 2.9% | 0.5% | 2.5% | 0.4% | 3.4% | 1.4% | 2.4% | 1.9% | |
| 5.2% | 10.1% | 6.3% | 9.0% | 15.5% | 9.8% | 1.9% | 6.2% | 0.8% | 4.5% | 4.4% | 6.7% | 4.1% | |
| 14.1% | 20.9% | 17.0% | 19.6% | 26.4% | 20.4% | 9.0% | 14.8% | 7.4% | 14.9% | 12.1% | 17.8% | 13.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.